These findings demonstrate that WNK2 downregulation stimulate the invasive activity of glioma cells through the action of MMP2, and that MMP2 inhibition, in cells with WNK2, will no further enhance the decrease in the invasion levels, suggesting therefore therapeutic relevance. This evidence concerns the gene MMP2 and glioma.